Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
Rev. Soc. Bras. Med. Trop
;
53: e20180498, 2020. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1057281
ABSTRACT
Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Pseudomonas aeruginosa
/
Infecciones por Pseudomonas
/
Infección Hospitalaria
Tipo de estudio:
Estudio de prevalencia
/
Factores de riesgo
Límite:
Humanos
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade Federal de São Paulo/BR
/
Universidade Presbiteriana Mackenzie/BR
Similares
MEDLINE
...
LILACS
LIS